Microwave-assisted synthesis and chiral HPLC separation of 18F-labeled MaxiPost™. An agent for post-stroke neuroprotection

The syntheses of (S)‐3‐(5‐chloro‐2‐methoxyphenyl)‐1,3‐dihydro‐3‐[18F]‐fluoro‐6‐(trifluoromethyl)‐1H‐indol‐2‐one was accomplished by the microwave assisted carrier‐added 18F fluorination of (R,S)‐3‐(5‐chloro‐2‐methoxyphenyl)‐1,3‐dihydro‐3‐chloro‐6‐(trifluoromethyl)‐1H‐indol‐2‐one, followed by chiral...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of labelled compounds & radiopharmaceuticals 2003-10, Vol.46 (12), p.1161-1171
Hauptverfasser: Dischino, Douglas D., Dulac, Heidi A., Gillman, Kevin W., Keller, Lynn S., Kozlowski, Edward S., Marcin, Lawrence R., Mongillo, James J., Starrett Jr, John E.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The syntheses of (S)‐3‐(5‐chloro‐2‐methoxyphenyl)‐1,3‐dihydro‐3‐[18F]‐fluoro‐6‐(trifluoromethyl)‐1H‐indol‐2‐one was accomplished by the microwave assisted carrier‐added 18F fluorination of (R,S)‐3‐(5‐chloro‐2‐methoxyphenyl)‐1,3‐dihydro‐3‐chloro‐6‐(trifluoromethyl)‐1H‐indol‐2‐one, followed by chiral HPLC separation to afford the desired 18F‐labeled enantiomer in radiochemical yields of 5–15% (EOS) and synthesis and purification times of 60–67 min. Biodistribution studies in rodents were consistent with previously reported studies using racemic 18F‐radiolabeled material. Copyright © 2003 John Wiley & Sons, Ltd.
ISSN:0362-4803
1099-1344
DOI:10.1002/jlcr.748